Insights

Loading spinner
Gathering insights about AstriVax

AstriVax Tech Stack

AstriVax uses 8 technology products and services including Open Graph, MySQL, oEmbed, and more. Explore AstriVax's tech stack below.

  • Open Graph
    Content Management System
  • MySQL
    Database
  • oEmbed
    Dev Tools
  • Microsoft 365
    Email
  • Font Awesome
    Font Scripts
  • JSON-LD
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • PHP
    Programming Languages

Media & News

AstriVax's Email Address Formats

AstriVax uses at least 1 format(s):
AstriVax Email FormatsExamplePercentage
First.Last@astrivax.comJohn.Doe@astrivax.com
40%
First.MiddleLast@astrivax.comJohn.MichaelDoe@astrivax.com
10%
First.Last@astrivax.comJohn.Doe@astrivax.com
40%
First.MiddleLast@astrivax.comJohn.MichaelDoe@astrivax.com
10%

Frequently Asked Questions

Where is AstriVax's headquarters located?

Minus sign iconPlus sign icon
AstriVax's main headquarters is located at Ambachtenlaan 1, Heverlee, Flemish Region 3001, BE. The company has employees across 1 continents, including Europe.

What is AstriVax's official website and social media links?

Minus sign iconPlus sign icon
AstriVax's official website is astrivax.com and has social profiles on LinkedInCrunchbase.

What is AstriVax's SIC code NAICS code?

Minus sign iconPlus sign icon
AstriVax's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AstriVax have currently?

Minus sign iconPlus sign icon
As of October 2025, AstriVax has approximately 35 employees across 1 continents, including Europe. Key team members include Chief Executive Officer: H. C.Chief Development Officer (cdo): M. P.Head Translational Immunology: F. S.. Explore AstriVax's employee directory with LeadIQ.

What industry does AstriVax belong to?

Minus sign iconPlus sign icon
AstriVax operates in the Biotechnology Research industry.

What technology does AstriVax use?

Minus sign iconPlus sign icon
AstriVax's tech stack includes Open GraphMySQLoEmbedMicrosoft 365Font AwesomeJSON-LDjQueryPHP.

What is AstriVax's email format?

Minus sign iconPlus sign icon
AstriVax's email format typically follows the pattern of First.Last@astrivax.com. Find more AstriVax email formats with LeadIQ.
AstriVax

AstriVax

Biotechnology ResearchBelgium11-50 Employees

AstriVax Therapeutics is a European based, clinical-stage biopharmaceutical company, founded in 2022, that is pioneering immune interventions to treat chronic disease. The company has two prototype prophylactic assets in clinical phase and is developing its therapeutic assets to treat chronic HBV and clear high-risk HPV. AstriVax has a novel DNA-launched viral vector immunotherapy platform, Launch-iT, that is designed to create an inherent adjuvant effect to the target antigens, eliciting durable polyfunctional CD8+ and CD4+ T cell responses and robust humoral immunity. Through Launch-iT, the company has the potential to develop best-in-class immunotherapy treatments.

Section iconCompany Overview

Headquarters
Ambachtenlaan 1, Heverlee, Flemish Region 3001, BE
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $1M

    AstriVax's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    AstriVax's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.